Caxton Associates (New York)’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,070
| Closed | -$512K | – | 706 |
|
|
2022
Q2 | $512K | Buy |
2,070
+258
| +14% | +$63.8K | 0.05% | 256 |
|
|
2022
Q1 | $600K | Buy |
+1,812
| New | +$600K | 0.05% | 183 |
|
|
2019
Q1 | – | Sell |
-1,165
| Closed | -$379K | – | 508 |
|
|
2018
Q4 | $379K | Sell |
1,165
-464
| -28% | -$151K | 0.06% | 141 |
|
|
2018
Q3 | $733K | Sell |
1,629
-1,339
| -45% | -$603K | 0.05% | 138 |
|
|
2018
Q2 | $1.21M | Sell |
2,968
-11
| -0.4% | -$4.5K | 0.06% | 108 |
|
|
2018
Q1 | $867K | Buy |
+2,979
| New | +$867K | 0.04% | 165 |
|